Stockscreener 앱 받기
3.835
0.17%
0.005
전일 마감가:
$3.83
열려 있는:
$3.79
하루 거래량:
340.22K
Relative Volume:
0.11
시가총액:
$431.36M
수익:
$1.88B
순이익/손실:
$-534.51M
주가수익비율:
-0.7449
EPS:
-5.1483
순현금흐름:
$4.76M
1주 성능:
-0.60%
1개월 성능:
+10.57%
6개월 성능:
-8.65%
1년 성능:
-50.17%
1일 변동 폭
$3.78
$3.92
1주일 범위
$3.715
$4.02
52주 변동 폭
$2.095
$12.06
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.835 | 430.80M | 1.88B | -534.51M | 4.76M | -5.1483 |
VEEV
Veeva Systems Inc
|
162.40 | 25.87B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
60.58 | 11.70B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.91 | 8.38B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.46 | 7.31B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
54.49 | 4.10B | 646.34M | -512.40M | 202.76M | -6.6871 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-11-13 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
Evolent Health Q1 earnings call highlights - MSN
EVH Stock Price Prediction 2025-2026 | Evolent Health Inc Forecast - 24/7 Wall St.
Evolent Health : EVH - 24/7 Wall St.
Analysts’ Top Healthcare Picks: ProMIS Neurosciences (PMN), Evolent Health (EVH) - The Globe and Mail
WATER ISLAND CREDIT OPPORTUNITIES FUND's Evolent Health Inc(EVH) Holding History - GuruFocus
Evolent Health to Participate in Upcoming Conferences - GuruFocus
EVH Maintained by Citigroup -- Price Target Raised to $5.50 - GuruFocus
Citigroup Adjusts Price Target on Evolent Health to $5.50 From $4, Maintains Buy Rating - Moomoo
Citi Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $5.5 - Moomoo
EVH Stock Price, Quote & Chart | EVOLENT HEALTH INCA (NYSE:EVH) - ChartMill
Earnings call transcript: Evolent Health Q1 2026 beats EPS, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: Evolent Health Q1 2026 beats EPS, stock surges - Investing.com UK
Evolent Health Price Target Raised to $6.00/Share From $4.00 by Canaccord Genuity - Moomoo
EVH Maintained by Canaccord Genuity -- Price Target Raised to $6 - GuruFocus
Evolent Health Is Maintained at Buy by Canaccord Genuity - Moomoo
CCORF Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
Canaccord raises Evolent Health stock price target on new wins By Investing.com - Investing.com South Africa
Canaccord raises Evolent Health stock price target on new wins - Investing.com
AI-focused health plan tools get new steward at Quest Analytics - Stock Titan
TD Cowen raises Evolent Health stock price target on recovery track - Investing.com UK
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $8 - Moomoo
TD Cowen raises Evolent Health stock price target on recovery track By Investing.com - Investing.com South Africa
Evolent Health Q1 Earnings Call Highlights - MarketBeat
Evolent Health, Inc (NYSE:EVH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Evolent Health(EVH) Stock Options Chain | Quotes & News - Moomoo
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $5 to $6 - Moomoo
Evolent Health, Inc. (NYSE:EVH) Just Released Its First-Quarter Earnings: Here's What Analysts Think - simplywall.st
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Evolent Health Earnings Call Balances Growth and Risk - TipRanks
MSN Money - MSN
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $5 to $5 - Moomoo
Evolent (EVH) Q1 2026 Earnings Call Transcript - AOL.com
BMO Capital Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
Evolent Health, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Evolent Health Q1 2026 slides: revenue misses forecast, leverage rises By Investing.com - Investing.com Australia
Evolent Health: Q1 Earnings Snapshot - theheraldreview.com
EVH Maintained by Needham -- Price Target Raised to $5.00 - GuruFocus
Evolent Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:EVH) 2026-05-07 - Seeking Alpha
Needham Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $5 - Moomoo
Why is Evolent Health (EVH) stock soaring today - MSN
Why Is Evolent Health (EVH) Stock Soaring Today - TradingView
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.18%
자본화:
|
볼륨(24시간):